ARCHIVES

Campath Improves PFS In B-Cell CLL In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 30 No. 1 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

Clinical Trials Approved by NCI CTEP Last Month

August 26, 2011

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

January 27, 2006

NCI Moves Slowly, Carcinogenesis CANCERGRAMS For May, June Missing

June 1, 1984

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007